Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.16%17.93B | 1.95%4.58B | 17.58%18.71B | 18.77%4.75B | 37.62%4.5B | 54.53%15.91B | 37.07%3.91B | 59.13%4.74B | 71.78%4B | 52.59%3.27B |
| Cost of revenue | -10.58%11.32B | -7.18%2.99B | 5.46%12.66B | 7.22%3.32B | 33.07%3.23B | 59.47%12B | 43.90%2.9B | 59.08%3.58B | 79.82%3.09B | 57.66%2.42B |
| Gross profit | 9.29%6.61B | 25.11%1.59B | 54.81%6.05B | 58.32%1.43B | 50.68%1.27B | 41.09%3.91B | 20.55%1B | 59.29%1.15B | 48.95%903M | 39.69%843.54M |
| Operating expense | -3.04%4.38B | -2.91%762.16M | 62.94%4.51B | 78.93%984.37M | 39.99%785.03M | 36.64%2.77B | 28.91%846.57M | 52.91%813.09M | 23.47%550.13M | 42.48%560.76M |
| Selling and administrative expenses | -3.63%4.35B | --784.48M | 63.77%4.51B | ---- | ---- | --2.76B | ---- | ---- | ---- | ---- |
| -General and administrative expense | -3.63%4.35B | --784.48M | 63.77%4.51B | ---- | ---- | --2.76B | ---- | ---- | ---- | ---- |
| Other operating expenses | 9,873.28%49.27M | --198K | -96.56%494K | ---- | ---- | -98.63%14.35M | ---- | ---- | ---- | ---- |
| Total other operating income | 12,526.11%22.73M | --22.51M | -0.55%180K | ---- | ---- | --181K | ---- | ---- | ---- | ---- |
| Operating profit | 45.62%2.23B | 70.37%828M | 34.97%1.53B | 26.19%445.26M | 71.87%486M | 53.26%1.13B | -10.49%158.24M | 76.89%341.02M | 119.64%352.87M | 34.47%282.78M |
| Net non-operating interest income (expenses) | 59.44%-7.6M | 153.45%1.56M | -193.79%-18.74M | -195.37%-3.95M | -863.91%-2.91M | -632.26%-6.38M | -283,400.00%-2.83M | -365.77%-1.91M | -203.40%-1.34M | -1,272.73%-302K |
| Non-operating interest income | 857.51%11.09M | 203,433.33%6.11M | 4,532.00%1.16M | 100.00%18K | 50.00%3K | 8.70%25K | 44.44%13K | -50.00%1K | -18.18%9K | 100.00%2K |
| Non-operating interest expense | -6.07%18.69M | 56.14%4.55M | 210.73%19.9M | 194.73%3.97M | 858.55%2.91M | 616.22%6.4M | 35,475.00%2.85M | 363.75%1.91M | 198.01%1.35M | 1,221.74%304K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | |||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | 4,533.33%139K | 134.38%11K | 0 | -78.57%3K | -136.78%-32K | |||||
| Income before tax | 46.92%2.22B | 71.72%829.55M | 34.07%1.51B | 29.94%441.3M | 71.04%483.1M | 51.31%1.13B | -8.48%167.36M | 76.28%339.12M | 111.95%339.61M | 34.27%282.44M |
| Income tax | 40.55%615.48M | 28.22%231.34M | 40.59%437.91M | -17.07%95.64M | 66.78%180.42M | 17.15%311.47M | -134.22%-21.79M | 69.22%109.76M | 77.33%115.33M | 49.65%108.18M |
| Net income | 49.52%1.61B | 97.64%598.21M | 31.59%1.08B | 54.12%345.66M | 73.69%302.68M | 70.23%817.06M | 58.71%189.15M | 79.87%229.36M | 135.60%224.28M | 26.21%174.26M |
| Net income continuous operations | 49.52%1.61B | 97.64%598.21M | 31.59%1.08B | 54.12%345.66M | 73.69%302.68M | 70.23%817.06M | 58.71%189.15M | 79.87%229.36M | 135.60%224.28M | 26.21%174.27M |
| Noncontrolling interests | -139.61%-24.47M | -137.77%-4.62M | 77.47%61.77M | 4,617.76%14.34M | 215.35%12.22M | 368.07%34.81M | 322.41%20.21M | 198.00%10.42M | 679.49%304K | 538.96%3.88M |
| Net income attributable to the company | 61.05%1.63B | 107.55%602.83M | 29.55%1.01B | 47.92%331.32M | 70.47%290.45M | 65.55%782.25M | 47.68%168.94M | 76.54%218.94M | 135.38%223.98M | 22.62%170.39M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 61.05%1.63B | 107.55%602.83M | 29.55%1.01B | 47.92%331.32M | 70.47%290.45M | 65.55%782.25M | 47.68%168.94M | 76.54%218.94M | 135.38%223.98M | 22.62%170.39M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 61.89%197.49 | 107.45%72.71 | 28.98%121.99 | 47.31%39.92 | 69.57%35.05 | 65.00%94.58 | 47.16%20.38 | 76.04%26.43 | 135.24%27.1 | 144.33%20.67 |
| Diluted earnings per share | 62.17%197.08 | 107.76%72.55 | 29.51%121.53 | 47.23%39.65 | 70.42%34.92 | 65.50%93.84 | 46.39%20.1 | 76.88%26.32 | 133.76%26.93 | 145.83%20.49 |
| Dividend per share | 59.68%99 | 0 | 34.78%62 | 0 | 0 | 58.62%46 | 58.62%46 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |